John Adam Zangerle Sells 1,419 Shares of STERIS (NYSE:STE) Stock

STERIS plc (NYSE:STE) VP John Adam Zangerle sold 1,419 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $209.28, for a total value of $296,968.32. Following the transaction, the vice president owned 35,259 shares in the company, valued at approximately $7,379,003.52. This represents a 3.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

STERIS Stock Down 3.6%

Shares of NYSE STE opened at $199.07 on Thursday. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44. The firm has a market cap of $19.40 billion, a price-to-earnings ratio of 25.10 and a beta of 0.93. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09. The stock’s 50-day simple moving average is $215.18 and its 200-day simple moving average is $235.86.

STERIS (NYSE:STE) last announced its earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.59 billion. STERIS had a return on equity of 14.15% and a net margin of 13.18%.The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, equities analysts anticipate that STERIS plc will post 11.18 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be given a dividend of $0.63 per share. The ex-dividend date is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.3%. STERIS’s payout ratio is currently 31.78%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Piper Sandler reiterated an “overweight” rating and set a $270.00 price objective on shares of STERIS in a research report on Thursday, May 21st. Weiss Ratings downgraded STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, May 27th. KeyCorp cut their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Finally, Wall Street Zen downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 6th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of STE. Board of the Pension Protection Fund bought a new position in shares of STERIS in the fourth quarter valued at $25,000. Western Wealth Management LLC bought a new position in shares of STERIS in the first quarter valued at $25,000. Harbor Investment Advisory LLC increased its holdings in shares of STERIS by 115.4% in the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 60 shares in the last quarter. Activest Wealth Management increased its holdings in shares of STERIS by 423.8% in the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 89 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC bought a new position in shares of STERIS in the fourth quarter valued at $28,000. Institutional investors own 94.69% of the company’s stock.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.